Icu Medical Inc
ICUI- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000883984
In the last 90 days, Icu Medical Inc insiders filed 0 open-market purchases and 7 sales; 288 institutions reported holding it in 13F filings for Q2 2026, worth $3.82B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Icu Medical Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 7 filings
- 6 insiders, $6.63M in total
- Insiders trading
- 6
- Net value
- −$6.63M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Icu Medical Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Sanzone Virginia Ruth | VP, General Counsel | 14,604 | Sep 3, 2026 | 5 |
| Bonnell Brian Michael | Chief Financial Officer | 56,062 | Sep 1, 2026 | 4 |
| Woolson Daniel | VP, GM-Infusion Capital | 17,062 | Aug 13, 2026 | 5 |
| Sousa Ben | Chief Information Officer | 3,076 | Aug 12, 2026 | 3 |
| Voigtlander Christian B. | Chief Operating Officer | 37,377 | Aug 11, 2026 | 3 |
| Finney Elisha W | Director | 4,871 | Aug 11, 2026 | 3 |
| Hoffmeister David F | Director | 6,004 | May 13, 2026 | 1 |
| Kennedy Kolleen T | Director | 4,539 | May 13, 2026 | 1 |
| Abbey Donald | Director | 6,004 | May 13, 2026 | 2 |
| Greenberg David C. | Director | 9,214 | May 13, 2026 | 1 |
| Hernandez Laurie | Director | 4,862 | May 13, 2026 | 1 |
| Jain Vivek | Chairman and CEO | 126,833 | Mar 16, 2026 | 2 |
| Lopez George A | Director | 877,343Indirect | Mar 14, 2024 | 0 |
| Smiths Group PLC | Other: Former 10% Owner | 1,670,000Indirect | Mar 1, 2024 | 0 |
| Smiths Group International Holdings Ltd | Other: Former 10% Owner | 1,670,000 | Mar 1, 2024 | 0 |
| McGrody Kevin J | Chief Accounting Officer | 4,846 | Mar 8, 2022 | 0 |
| Swinney Robert S | Director | 20,816 | Sep 15, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 14, 2023 (view filing) | Jul 12 | 2 days | Jain VivekChairman and CEO | SSale | −30.0K | $180.02 | −$5.40M | −55.9%23.7K after | 10b5-1 |
| Jun 15, 2023 (view filing) | Jun 14 | 1 day | Jain VivekChairman and CEO | SSale | −30.0K | $188.67 | −$5.66M | −55.9%23.7K after | 10 lots10b5-1 |
| Jun 7, 2023 (view filing) | Jun 7 | Same day | Finney Elisha WDirector | SSale | −194 | $190.41 | −$36.9K | −11.6%1.48K after | 10b5-1 |
| Apr 11, 2023 (view filing) | Apr 11 | Same day | Sanzone Virginia RuthVP, General Counsel | SSale | −250 | $175.00 | −$43.8K | −5.1%4.68K after | 10b5-1 |
| Apr 5, 2023 (view filing) | Apr 5 | Same day | Sanzone Virginia RuthVP, General Counsel | SSale | −458 | $170.00 | −$77.9K | −8.5%4.93K after | 10b5-1 |
| Feb 2, 2023 (view filing) | Feb 2 | Same day | Woolson DanielVP, GM-Infusion Capital | SSale | −1.73K | $200.00 | −$346.2K | −15.9%9.15K after | |
| Nov 15, 2022 (view filing) | Nov 15 | Same day | Sanzone Virginia RuthVP, General Counsel | SSale | −325 | $160.12 | −$52.0K | −9.6%3.05K after | |
| May 13, 2022 (view filing) | May 12 | 1 day | Lopez George ADirector | PPurchase | +25.8K | $172.91 | +$4.47M | +10.1%281.4K after | 5 lots |
| May 12, 2022 (view filing) | May 12 | Same day | Sanzone Virginia RuthVP, General Counsel | SSale | −750 | $173.56 | −$130.2K | −18.2%3.37K after | |
| May 12, 2022 (view filing) | May 12 | Same day | Finney Elisha WDirector | SSale | −217 | $170.53 | −$37.0K | −10.1%1.93K after | |
| Mar 4, 2022 (view filing) | Mar 3 | 1 day | Jain VivekChairman and CEO | SSale | −36.0K | $240.00 | −$8.64M | −73.8%12.8K after | |
| Dec 30, 2021 (view filing) | Dec 28-30 | 2 days | Jain VivekChairman and CEO | SSale | −12.0K | $240.00 | −$2.88M | −48.4%12.8K after | 3 lots |
| Nov 5, 2021 (view filing) | Nov 3 | 2 days | Jain VivekChairman and CEO | SSale | −24.0K | $240.00 | −$5.76M | −65.3%12.8K after | 2 lots |
| Sep 15, 2021 (view filing) | Sep 15 | Same day | Swinney Robert SDirector | SSale | −2.16K | $243.00 | −$524.2K | −9.4%20.8K after | |
| Sep 14, 2021 (view filing) | Sep 14 | Same day | Finney Elisha WDirector | SSale | −2.42K | $242.20 | −$587.1K | −58.5%1.72K after | |
| Sep 13, 2021 (view filing) | Sep 10 | 3 days | Sanzone Virginia RuthVP, General Counsel | SSale | −800 | $251.55 | −$201.2K | −33.3%1.60K after | 3 lots |